HIITing Anxiety and Depression in Parkinson’s Disease and Multiple Sclerosis—A Study Protocol of a Transdiagnostic Randomized Controlled Trial (HersenFIT)
<b>Background/Objectives:</b> Parkinson's disease (PD) and multiple sclerosis (MS) are neurological conditions that result in debilitating non-motor symptoms, such as anxiety and depression, which significantly reduce quality of life and often persist despite pharmacological treatment. As a result, effective alternative treatment strategies are needed. Exercise therapy-particularly aerobic training-has shown promise in alleviating non-motor symptoms, potentially through neuroplastic adaptations. However, traditional aerobic exercise is often time-consuming and monotonous, limiting long-term adherence. High-intensity interval training (HIIT) offers a time-efficient and potentially more engaging alternative, though its effects on non-motor symptoms in PD and MS remain understudied. <b>Methods</b>: This transdiagnostic randomized controlled trial will enroll 48 participants (24 PD, 24 MS) with clinically significant affective symptoms (hospital anxiety and depression scale [HADS] ≥ 8). The participants will be randomly assigned to one of three 8-week interventions: (1) HIIT, 5-6 intervals of 45 s of high-intensity cycling; (2) continuous aerobic training (CAT), 50 min of low-intensity cycling; (3) movement advice (MA), step goals, and physical education. The primary (affective symptoms) and secondary outcomes (cognition, fatigue, sleep, motor function) will be assessed at four time points: 4 and 1 weeks pre intervention, and 1 and 4 weeks post intervention. Weekly blood samples and pre/post brain imaging will be collected to study biofluid and MRI measures for potential neuroplasticity. Linear mixed models will analyze the time and group effects. <b>Discussion:</b> This trial will assess whether HIIT can more effectively improve non-motor and motor symptoms in PD and MS than CAT or MA. A multimodal approach will explore both the clinical outcomes and underlying mechanisms, informing scalable and engaging rehabilitation strategies.
Authors
- Chris Vriend (ORCID: https://orcid.org/0000-0003-3111-1304)
- Arianne Sophia Gravesteijn (ORCID: https://orcid.org/0000-0002-2458-2346)
- Marc B. Rietberg (ORCID: https://orcid.org/0000-0002-0257-7431)
- Erwin E. H. van Wegen (ORCID: https://orcid.org/0000-0002-7920-9995)
- Mark A. Hirsch (ORCID: https://orcid.org/0000-0002-8997-7971)
- Vincent de Groot (ORCID: https://orcid.org/0000-0002-6073-6250)
- Richard T. Jaspers (ORCID: https://orcid.org/0000-0002-6951-0952)
- Wilma D. J. van de Berg (ORCID: https://orcid.org/0000-0002-6175-5357)
- Tim Vanbellingen (ORCID: https://orcid.org/0000-0002-0884-2005)
- Odile A. van den Heuvel
Institutions
- University of Bern (CH)
- Multiple Sclerose Vereniging Nederland (NL)
- Amsterdam Neuroscience (NL)
- Veterinary Anaesthesia Services (Switzerland) (CH)
- GGD Amsterdam (NL)
- MSD (Netherlands) (NL)
- Wake Forest University (US)
- Amsterdam University of Applied Sciences (NL)
- Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- Brain Sciences
- Published
- 2025-08-29
- DOI
- https://doi.org/10.3390/brainsci15090945
- Citations
- 1
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- Amsterdam University Medical Centers